A Multicenter, Double-Blind, Active-Controlled, Parallel Group Study to Examine the Safety, Tolerability and Efficacy of Oral MK-0974 for the Long Term Treatment of Acute Migraine With or Without Aura
Phase of Trial: Phase III
Latest Information Update: 31 Jul 2017
At a glance
- Drugs Telcagepant (Primary) ; Rizatriptan
- Indications Migraine; Migraine with aura; Migraine without aura
- Focus Adverse reactions; Registrational
- Sponsors Merck Sharp & Dohme
- 04 Jul 2012 Company added in association field as reported by European Clinical Trials Database.
- 04 Jul 2012 Additional trial locations added as reported by European Clinical Trials Database.
- 10 Sep 2009 Results reported at the Joint Meeting of the 14th International Headache Congress & the 51st Annual Scientific Meeting of the American Headache Society (IHC/AHS 2009).